bromocriptine has been researched along with dantrolene in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (34.38) | 18.7374 |
1990's | 25 (39.06) | 18.2507 |
2000's | 13 (20.31) | 29.6817 |
2010's | 2 (3.13) | 24.3611 |
2020's | 2 (3.13) | 2.80 |
Authors | Studies |
---|---|
Chiang, WK; Herschman, Z | 1 |
Becker, H; Bittkau, S; Przuntek, H; Schröder, J; Sczesni, B; Truong, DD; von Baumgarten, F | 1 |
Davis, JM; Janicak, PG; Sakkas, P; Wang, ZY | 1 |
Retamal, P | 1 |
Mazurek, MF; Rosebush, PI; Stewart, T | 1 |
Epperly, TD; Leo, KU; McGlaughlin, VG | 1 |
Baca, L; Martinelli, L | 1 |
Delerue, O; Destée, A | 1 |
Chinyanga, HM; Constantinou, E; Haisma, HJ | 1 |
Björk, E; Hallberg, A; Martinussen, HJ; Trost, AC | 1 |
Hippius, H; Spiess-Kiefer, C | 1 |
Lazarus, A | 3 |
Jeste, DV; Sewell, DD | 1 |
Levenson, JL | 1 |
Gorelick, PB; Greenberg, MS | 1 |
Munitz, H; Shalev, A | 1 |
Donovan, K; Fahn, S; Gross, J; Sczesni, B; Truong, DD; van Bakel, A; Wiley, MK | 1 |
Olmsted, TR | 1 |
Guerrero, RM; Shifrar, KA | 1 |
Andrade, NN | 1 |
Abbott, RJ; Loizou, LA | 1 |
Sahn, SA | 1 |
Baxter, LR; Guzé, BH | 1 |
Ciolino, C; Rosse, R | 1 |
Lucid, EJ; Martin, ML; Walker, RW | 1 |
Neppe, VM | 1 |
White, PD | 1 |
Peters, FD; Schumacher, T | 1 |
Adler, S; Coyle, J; Granato, JE; Karim, AH; Krumholz, A; Ringel, A; Stern, BJ | 1 |
Rónai, L; Wagner, G | 1 |
Raheja, R; Singerman, B | 1 |
Marken, PA; Schneiderhan, ME | 1 |
Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK | 1 |
Minnema, AM; Reddig, S; Tandon, R | 1 |
Becker, BN; Ismail, N | 1 |
Byrd, C | 1 |
Benard, A; Guenanen, H; Tillie-Leblond, I; Wallaert, B | 1 |
Baud, FJ; Benaissa, M; Clemessy, JL; Hantson, P | 1 |
Alted Lopez, E; Ambros Checa, A; Caballero Cubedo, R; Perez-Vela, JL; Sanchez Casado, M; Sanchez-Izquierdo Riera, JA | 1 |
Grande Rodríguez, S; Real Rodríguez, B; Ruibal, JL; Sueiro Pita, B | 1 |
Deppe, S; Epperly, N; Friedman, B; Law, E; Orlet, H; Still, J | 1 |
Miyoshi, T; Motomura, S; Osoegawa, M; Tamura, K; Yamanaka, H | 1 |
Barron, TF; Dayner, J; Trasmonte, J | 1 |
Koyama, T; Kusumi, I | 1 |
Privette, T; Stanfield, SC | 1 |
Agrawal, M; Krishnan, P; Niranjan, S; Patel, U | 1 |
Reingardiene, D | 1 |
Nishijima, K | 1 |
Ananth, J; Burgoyne, K; Gunatilake, S; Parameswaran, S; Sidhom, T | 1 |
Amaro, S; Gaig, C; Gómez-Choco, MJ; Martí, MJ; Tolosa, E | 1 |
Nagamine, M; Nomura, S; Sakurai, Y; Sanga, M; Takahashi, R; Yoshino, A | 1 |
Collumbien, EC; Smidt, MH | 1 |
Caroff, SN; Keck, PE; Strawn, JR | 1 |
Santens, P; Vancaester, E | 1 |
Furuno, T; Kawanishi, C; Kishida, I | 1 |
Joshi, AS; Khobragade, AK; Patel, AL; Sahastrabuddhe, GS; Shaikh, WA; Soni, HG | 1 |
Ikushima, G; Kameda, K; Koinuma, M; Shoko, T; Takahashi, K; Watarai, K | 1 |
Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P | 1 |
Kamiyama, T; Mizuno, T; Suzuki, A; Suzuki, M; Takahashi, R | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
17 review(s) available for bromocriptine and dantrolene
Article | Year |
---|---|
[Neuroleptic malignant syndrome].
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome | 1990 |
Neuroleptic malignant syndrome.
Topics: Amantadine; Brain; Bromocriptine; Dantrolene; Humans; Neuroleptic Malignant Syndrome; Prognosis | 1989 |
Neuroleptic malignant syndrome: a review.
Topics: Bromocriptine; Dantrolene; Diagnosis, Differential; Heat Exhaustion; Humans; Neuroleptic Malignant Syndrome; Recurrence; Risk Factors | 1989 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Child; Dantrolene; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Female; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Receptors, Dopamine; Rhabdomyolysis; Schizophrenia | 1985 |
The neuroleptic malignant syndrome: agent and host interaction.
Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome | 1986 |
Neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Animals; Body Temperature; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Muscle Rigidity; Neuroleptic Malignant Syndrome; Rats | 1986 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Granulomatosis with Polyangiitis; Heart Injuries; Humans; Immune System Diseases; Immunoblastic Lymphadenopathy; Lupus Erythematosus, Systemic; Male; Methotrexate; Methysergide; Middle Aged; Myocardial Infarction; Nitrofurantoin; Pacemaker, Artificial; Pleural Diseases; Pleural Effusion; Practolol; Procarbazine; Rheumatic Diseases; Sarcoidosis; Syndrome; Thoracic Injuries | 1985 |
Current concepts. Neuroleptic malignant syndrome.
Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Drug Interactions; Heat Exhaustion; Humans; Malignant Hyperthermia; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Parasympatholytics | 1985 |
Malignant catatonia--a continuing reality.
Topics: Adult; Aged; Antipsychotic Agents; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Lorazepam; Male; Middle Aged | 1994 |
[Drug-induced pleurisy].
Topics: Bromocriptine; Dantrolene; Dopamine Agonists; Ergotamines; Fibrosis; Humans; Muscle Relaxants, Central; Pleura; Pleural Diseases; Pleural Effusion; Pleurisy | 1996 |
[The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Dantrolene; Diazepam; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Lorazepam; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Time Factors | 1996 |
Algorithms for the treatment of acute side effects induced by neuroleptics.
Topics: Algorithms; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Japan; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome | 1999 |
[Neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis | 2002 |
[Neuroleptic malignant syndrome].
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Diazepam; Dopamine D2 Receptor Antagonists; Electroconvulsive Therapy; Fluid Therapy; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Receptors, Dopamine D2; Reference Standards; Secondary Prevention | 2003 |
Neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Dantrolene; Diagnosis, Differential; Dopamine; Electroconvulsive Therapy; Female; Humans; Lorazepam; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Risk Factors | 2007 |
[Drug-induced neuroleptic malignant syndrome].
Topics: Biomarkers; Bromocriptine; Creatine Kinase, MM Form; Cytochrome P-450 CYP2D6; Dantrolene; Diagnosis, Differential; Dopamine Agonists; Dopamine Antagonists; Humans; Neuroleptic Malignant Syndrome; Polymorphism, Genetic; Psychotropic Drugs; Reference Standards; Risk Factors; Time Factors | 2007 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
47 other study(ies) available for bromocriptine and dantrolene
Article | Year |
---|---|
Lethal catatonia and neuroleptic malignant syndrome.
Topics: Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome | 1992 |
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lisuride; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia | 1991 |
Drug treatment of the neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Dantrolene; Dihydroxyphenylalanine; Dopamine Agents; Humans; Neuroleptic Malignant Syndrome | 1991 |
The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?
Topics: Adult; Bromocriptine; Combined Modality Therapy; Critical Care; Dantrolene; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Neurologic Examination; Prospective Studies | 1991 |
A hazardous side effect of neuroleptics: diagnosis and treatment.
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome | 1990 |
Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant.
Topics: Bromocriptine; Dantrolene; Desipramine; Dopamine; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Norepinephrine | 1990 |
[Protracted recurrent neuroleptic malignant syndrome].
Topics: Adult; Bromocriptine; Dantrolene; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Recurrence | 1990 |
Neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Chlorpromazine; Dantrolene; Female; Haloperidol; Humans; Lithium; Neuroleptic Malignant Syndrome | 1990 |
[Neuroleptic malignant syndrome--life-threatening but treatable].
Topics: Adult; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Prognosis | 1990 |
[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
Topics: Adult; Amantadine; Bromocriptine; Calcium; Cross-Sectional Studies; Dantrolene; Female; Humans; Ion Channels; Male; Malignant Hyperthermia; Muscle Contraction; Muscular Diseases; Neuroleptic Malignant Syndrome; Risk | 1986 |
Diagnosing and treating neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Bromocriptine; Creatine Kinase; Dantrolene; Humans; Muscle Rigidity; Neuroleptic Malignant Syndrome; Terminology as Topic | 1986 |
Rigidity and fever in two psychotic patients.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Psychotic Disorders | 1986 |
[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
Topics: Adult; Aged; Antipsychotic Agents; Brain; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary; Receptors, Dopamine; Schizophrenia | 1988 |
Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics.
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome | 1988 |
Diagnosis and treatment of neuroleptic malignant syndrome.
Topics: Adolescent; Amantadine; Animals; Bromocriptine; Dantrolene; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome | 1988 |
Emergency treatment of the neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Clinical Protocols; Dantrolene; Emergencies; Humans; Male; Neuroleptic Malignant Syndrome | 1988 |
Therapy of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine | 1986 |
Dopamine agonists and neuroleptic malignant syndrome.
Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome | 1985 |
Neuroleptic malignant syndrome.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Diagnosis, Differential; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome | 1985 |
The neuroleptic malignant syndrome. A priority system.
Topics: Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Consciousness Disorders; Dantrolene; Fever; Humans; Muscle Rigidity; Phenytoin; Syndrome | 1984 |
Treatment of neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans | 1984 |
Treating neuroleptic malignant syndrome.
Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans; Muscle Rigidity | 1984 |
[Possibilities of the drug modification of the urethra and urinary bladder].
Topics: Baclofen; Bromocriptine; Dantrolene; Flavoxate; Humans; Imipramine; Male; Parasympatholytics; Parasympathomimetics; Prostaglandins; Sympatholytics; Sympathomimetics; Urethra; Urinary Bladder | 1983 |
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Drug Therapy, Combination; Fluphenazine; Humans; Male; Schizophrenia | 1983 |
[Acute renal failure in neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Renal Dialysis; Rhabdomyolysis | 1995 |
An atypical course of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Dantrolene; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia, Aspiration; Psychiatric Department, Hospital; Renal Insufficiency; Time Factors | 1994 |
Management of neuroleptic malignant syndrome--a series of eight cases.
Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome | 1993 |
Neuroleptic malignant syndrome and clozapine.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dantrolene; Diagnosis, Differential; Fever; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Schizophrenia | 1993 |
The neuroleptic malignant syndrome and acute renal failure.
Topics: Acute Kidney Injury; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Water-Electrolyte Imbalance | 1994 |
Neuroleptic malignant syndrome: a dangerous complication of neuroleptic therapy.
Topics: Adult; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome | 1993 |
Hyperthermia complicating tricyclic antidepressant overdose.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Body Temperature; Bromocriptine; Cryotherapy; Dantrolene; Dopamine Agonists; Fatal Outcome; Female; Fever; Humans; Middle Aged; Muscle Relaxants, Central; Shock | 1996 |
Neuroleptic malignant syndrome in a patient with head injury.
Topics: Adolescent; Bromocriptine; Craniocerebral Trauma; Creatine Kinase; Dantrolene; Hemofiltration; Humans; Male; Multiple Trauma; Neuroleptic Malignant Syndrome; Pancuronium; Rhabdomyolysis | 1996 |
Neuroleptic malignant syndrome in a burn patient.
Topics: Accidents, Occupational; Adult; Antipsychotic Agents; Bromocriptine; Burns; Dantrolene; Debridement; Delirium; Dopamine Agonists; Fever; Follow-Up Studies; Haloperidol; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Surgical Wound Infection | 1998 |
[A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Topics: Anticoagulants; Antiparkinson Agents; Bromocriptine; Dantrolene; Disseminated Intravascular Coagulation; Female; Gabexate; Humans; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Parkinson Disease; Status Epilepticus | 1999 |
Neuroleptic malignant syndrome in an adolescent head trauma patient.
Topics: Accidents, Traffic; Adolescent; Age Factors; Anti-Dyskinesia Agents; Bromocriptine; Craniocerebral Trauma; Dantrolene; Female; Haloperidol; Humans; Motorcycles; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome | 1999 |
Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Combined Modality Therapy; Cryotherapy; Dantrolene; Dopamine Agonists; Emergency Treatment; Hemiplegia; Humans; Intubation, Intratracheal; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2000 |
Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea.
Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Pulmonary Edema | 2002 |
Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Clozapine; Dantrolene; Dibenzothiazepines; Dopamine Agonists; Female; Humans; Intubation; Male; MEDLINE; Mental Disorders; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Respiration, Artificial; Risperidone; Treatment Outcome | 2004 |
Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever of Unknown Origin; Heat Stroke; Humans; Infections; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Parkinsonian Disorders | 2005 |
Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery.
Topics: Aged; Antipsychotic Agents; Body Temperature; Bromocriptine; Cause of Death; Creatine Kinase; Dantrolene; Dopamine Agonists; Female; Humans; Japan; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Retrospective Studies; Risk Factors | 2005 |
[A cocaine-induced variant of the neuroleptic malignant syndrome. A case study].
Topics: Bromocriptine; Cocaine; Dantrolene; Dopamine Agonists; Humans; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Schizophrenia; Treatment Outcome | 2006 |
Catatonia and neuroleptic malignant syndrome: two sides of a coin?
Topics: Adult; Aged; Alcoholism; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Brain Injuries; Bromocriptine; Catatonia; Dantrolene; Depression; Dopamine Agonists; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychotic Disorders | 2007 |
Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Dantrolene; Dopamine Agonists; Electroconvulsive Therapy; Female; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome | 2008 |
Pharmaceutical Approach for the Diagnosis and Treatment of Malignant Syndrome: A Case Study.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Drug Therapy, Combination; Haloperidol; Humans; Hydroxyzine; Infusions, Intravenous; Interdisciplinary Communication; Male; Neuroleptic Malignant Syndrome; Patient Care Team; Pharmaceutical Services; Treatment Outcome; Young Adult | 2016 |
Neuroleptic malignant syndrome in a COVID-19 patient.
Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia | 2020 |
Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; BNT162 Vaccine; Bromocriptine; COVID-19; Dantrolene; Humans; Hydrocortisone; Male; Middle Aged; Neuroleptic Malignant Syndrome; Vaccination; Valproic Acid | 2022 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |